TITLE

Gynecomastia: Complications of the Subcutaneous Mastectomy

AUTHOR(S)
Steele, Scott R.; Martin, Matthew J.; Place, Ronald J.
PUB. DATE
February 2002
SOURCE
American Surgeon;Feb2002, Vol. 68 Issue 2, p210
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Gynecomastia is a benign enlargement of the male breast secondary to gland proliferation. Subcutaneous mastectomy is performed for symptomatic patients and in those desiring cosmetic changes. The aim of this study was to assess the risk factors and complications associated with the operation. We retrospectively examined the records of all patients undergoing a subcutaneous mastectomy for gynecomastia. Ninety-one patients were identified. We conducted telephone interviews with 52 patients and performed 65 subcutaneous mastectomies on those 52 patients. Thirty of the 65 procedures (46%) developed complications. These included sensory changes, pain, seromas, scarring, breast asymmetry, hematomas, and wound infection. No preoperative risk factors were significant for postoperative complications. Eighteen of 22 cases with drains placed intraoperatively developed complications as compared with 12 of 43 cases without drains (P = 2.6 x 10[sup -7]). Specimens removed from the patients who had drains placed were significantly larger than those from patients who did not have drains placed (P = 1.5 x 10[sup -5]). However, specimen size was not an independent risk factor for development of a complication (P = 0.14). We found a relatively high complication rate in subcutaneous mastectomy for gynecomastia. Most complications are minor with no long-term effect. Drain placement was the only risk factor associated with postoperative complications.
ACCESSION #
6596461

 

Related Articles

  • Gynecomastia: When breasts form in males.  // American Family Physician;4/1/1997, Vol. 55 Issue 5, p1849 

    Presents information gynecomastia, a condition in which firm breast tissue forms in males. Causes of gynecomastia; Laboratory tests needed to find the cause of gynecomastia; Treatment for gynecomastia.

  • Hypodermoclysis: An Alternative Infusion Technique. Sasson, Menahem; Shvartzman, Pesach // American Family Physician;11/1/2001, Vol. 64 Issue 9, p1575 

    Hypodermoclysis, the subcutaneous infusion of fluids, is a useful and easy hydration technique suitable for mildly to moderately dehydrated adult patients, especially the elderly. The method is considered safe and does not pose any serious complications. The most frequent adverse effect is mild...

  • Phantom breast pain following mastectomy. Scholz, Mary J. // RN;Aug93, Vol. 56 Issue 8, p78 

    Provides information on phantom breast pain following a mastectomy. Increase in incidence of phantom breast pain over a six-year period; Phantom sensation of breast's existence remaining the same; Other statistics on phantom pains.

  • Impact of Fat Layers on Lesion Development during HIFU Application — A Precise Experimental Analysis. Divkovic, G. Wilzbach; Huber, P. E.; Jenne, J. W. // AIP Conference Proceedings;2007, Vol. 911 Issue 1, p232 

    High intensity focused ultrasound (HIFU) provides a noninvasive method for thermal tissue destruction. Local changes in acoustic properties occurring in tissue during the heating procedure, referred to in the literature as “thermal lens effect”, lead to ultrasound beam distortion and...

  • Digoxin/furosemide interaction.  // Reactions Weekly;5/15/2010, Issue 1301, p19 

    The article describes the case of a 23-year-old man who acquired gynaecomastia in his left breast while undergoing treatment with digoxin and furosemide.

  • Question 2 Which medications effectively reduce pubertal gynaecomastia?  // Archives of Disease in Childhood;Mar2010, Vol. 95 Issue 3, p237 

    The article provides an answer to a question regarding the effective medications to reduce pubertal gynaecomastia.

  • Dose Scheduling – Herceptin[sup ®]. Leyland-Jones, Brian // Oncology;2001 Supplement 2, Vol. 61, p31 

    Preclinical and phase I/II studies of Herceptin[sup ®] demonstrated a dose-related, non-linear pharmacokinetic profile. The results of a dose-finding study supported a regimen comprising an initial intravenous (i.v.) dose of 4 mg/kg with subsequent weekly doses of 2 mg/kg. However,...

  • Successful Percutaneous Dihydrotestosterone Treatment of Gynecomastia Occurring during Highly Active Antiretroviral Therapy: Four Cases and a Review of the Literature. Benveniste, Olivier; Simon, Anne; Herson, Serge // Clinical Infectious Diseases;9/15/2001, Vol. 33 Issue 6, p891 

    Fourteen cases of gynecomastia occurring during highly active antiretroviral therapy (HAART) have been reported in the literature. To date, no specific therapeutic approach has been proposed, and gynecomastia has usually persisted. We report 4 new cases of HAART-induced gynecomastia that were...

  • Mastectomy skin flap necrosis: challenges and solutions. Robertson, Stuart A.; Jeevaratnam, Johann A.; Agrawal, Avi; Cutress, Ramsey I. // Breast Cancer: Targets & Therapy;Mar2017, Vol. 9, p141 

    Introduction: Mastectomy skin flap necrosis (MSFN) has a reported incidence of 5%-30% in the literature. It is often a significant and underappreciated problem. The aim of this article was to review the associated challenges and possible solutions. Methods: A MEDLINE search was performed using...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics